Global Ophthalmol Drug Market Research Report 2021
Table of Contents1 Ophthalmol Drug Market Overview
1.1 Product Overview and Scope of Ophthalmol Drug
1.2 Ophthalmol Drug Segment by Type
1.2.1 Global Ophthalmol Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Retinal disorders drugs
1.2.3 Allergic, inflammatory and infective drugs
1.2.4 Glaucoma drugs
1.2.5 Dry eye drugs
1.3 Ophthalmol Drug Segment by Application
1.3.1 Ophthalmol Drug Sales Comparison by Application: (2021-2027)
1.3.2 Glaucoma
1.3.3 Dry eye syndrome
1.3.4 Retinal diseases
1.3.5 Other ophthalmic indications
1.4 Global Ophthalmol Drug Market Size Estimates and Forecasts
1.4.1 Global Ophthalmol Drug Revenue 2016-2027
1.4.2 Global Ophthalmol Drug Sales 2016-2027
1.4.3 Ophthalmol Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Ophthalmol Drug Market Competition by Manufacturers
2.1 Global Ophthalmol Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Ophthalmol Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Ophthalmol Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Ophthalmol Drug Manufacturing Sites, Area Served, Product Type
2.5 Ophthalmol Drug Market Competitive Situation and Trends
2.5.1 Ophthalmol Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Ophthalmol Drug Players Market Share by Revenue
2.5.3 Global Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmol Drug Retrospective Market Scenario by Region
3.1 Global Ophthalmol Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Ophthalmol Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Ophthalmol Drug Market Facts & Figures by Country
3.3.1 North America Ophthalmol Drug Sales by Country
3.3.2 North America Ophthalmol Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ophthalmol Drug Market Facts & Figures by Country
3.4.1 Europe Ophthalmol Drug Sales by Country
3.4.2 Europe Ophthalmol Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ophthalmol Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Ophthalmol Drug Sales by Region
3.5.2 Asia Pacific Ophthalmol Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Ophthalmol Drug Market Facts & Figures by Country
3.6.1 Latin America Ophthalmol Drug Sales by Country
3.6.2 Latin America Ophthalmol Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Ophthalmol Drug Sales by Country
3.7.2 Middle East and Africa Ophthalmol Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Ophthalmol Drug Historic Market Analysis by Type
4.1 Global Ophthalmol Drug Sales Market Share by Type (2016-2021)
4.2 Global Ophthalmol Drug Revenue Market Share by Type (2016-2021)
4.3 Global Ophthalmol Drug Price by Type (2016-2021)
5 Global Ophthalmol Drug Historic Market Analysis by Application
5.1 Global Ophthalmol Drug Sales Market Share by Application (2016-2021)
5.2 Global Ophthalmol Drug Revenue Market Share by Application (2016-2021)
5.3 Global Ophthalmol Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Allergan Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Roche Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Valeant
6.4.1 Valeant Corporation Information
6.4.2 Valeant Description and Business Overview
6.4.3 Valeant Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Valeant Product Portfolio
6.4.5 Valeant Recent Developments/Updates
6.5 Regeneron
6.5.1 Regeneron Corporation Information
6.5.2 Regeneron Description and Business Overview
6.5.3 Regeneron Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Regeneron Product Portfolio
6.5.5 Regeneron Recent Developments/Updates
6.6 Santen
6.6.1 Santen Corporation Information
6.6.2 Santen Description and Business Overview
6.6.3 Santen Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Santen Product Portfolio
6.6.5 Santen Recent Developments/Updates
6.7 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bayer Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Pfizer Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Senju
6.9.1 Senju Corporation Information
6.9.2 Senju Description and Business Overview
6.9.3 Senju Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Senju Product Portfolio
6.9.5 Senju Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Ophthalmol Drug Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Akorn Product Portfolio
6.10.5 Akorn Recent Developments/Updates
7 Ophthalmol Drug Manufacturing Cost Analysis
7.1 Ophthalmol Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ophthalmol Drug
7.4 Ophthalmol Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ophthalmol Drug Distributors List
8.3 Ophthalmol Drug Customers
9 Ophthalmol Drug Market Dynamics
9.1 Ophthalmol Drug Industry Trends
9.2 Ophthalmol Drug Growth Drivers
9.3 Ophthalmol Drug Market Challenges
9.4 Ophthalmol Drug Market Restraints
10 Global Market Forecast
10.1 Ophthalmol Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ophthalmol Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Ophthalmol Drug by Type (2022-2027)
10.2 Ophthalmol Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ophthalmol Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Ophthalmol Drug by Application (2022-2027)
10.3 Ophthalmol Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ophthalmol Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Ophthalmol Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Ophthalmol Drug Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Ophthalmol Drug Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Ophthalmol Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Ophthalmol Drug Covered in This Study
Table 5. Global Ophthalmol Drug Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Ophthalmol Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Ophthalmol Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Ophthalmol Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Ophthalmol Drug Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Ophthalmol Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Ophthalmol Drug Product Type
Table 12. Global Ophthalmol Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ophthalmol Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmol Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Ophthalmol Drug Sales by Region (2016-2021) & (K MT)
Table 16. Global Ophthalmol Drug Sales Market Share by Region (2016-2021)
Table 17. Global Ophthalmol Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Ophthalmol Drug Sales by Country (2016-2021) & (K MT)
Table 19. North America Ophthalmol Drug Sales Market Share by Country (2016-2021)
Table 20. North America Ophthalmol Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Ophthalmol Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Ophthalmol Drug Sales by Country (2016-2021) & (K MT)
Table 23. Europe Ophthalmol Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Ophthalmol Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Ophthalmol Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Ophthalmol Drug Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Ophthalmol Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Ophthalmol Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Ophthalmol Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Ophthalmol Drug Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Ophthalmol Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Ophthalmol Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Ophthalmol Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Ophthalmol Drug Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Ophthalmol Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Ophthalmol Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Ophthalmol Drug Sales (K MT) by Type (2016-2021)
Table 39. Global Ophthalmol Drug Sales Market Share by Type (2016-2021)
Table 40. Global Ophthalmol Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Ophthalmol Drug Revenue Share by Type (2016-2021)
Table 42. Global Ophthalmol Drug Price (USD/MT) by Type (2016-2021)
Table 43. Global Ophthalmol Drug Sales (K MT) by Application (2016-2021)
Table 44. Global Ophthalmol Drug Sales Market Share by Application (2016-2021)
Table 45. Global Ophthalmol Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Ophthalmol Drug Revenue Share by Application (2016-2021)
Table 47. Global Ophthalmol Drug Price (USD/MT) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Novartis Ophthalmol Drug Product
Table 52. Novartis Recent Developments/Updates
Table 53. Allergan Corporation Information
Table 54. Allergan Description and Business Overview
Table 55. Allergan Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Allergan Ophthalmol Drug Product
Table 57. Allergan Recent Developments/Updates
Table 58. Roche Corporation Information
Table 59. Roche Description and Business Overview
Table 60. Roche Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Roche Ophthalmol Drug Product
Table 62. Roche Recent Developments/Updates
Table 63. Valeant Corporation Information
Table 64. Valeant Description and Business Overview
Table 65. Valeant Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Valeant Ophthalmol Drug Product
Table 67. Valeant Recent Developments/Updates
Table 68. Regeneron Corporation Information
Table 69. Regeneron Description and Business Overview
Table 70. Regeneron Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Regeneron Ophthalmol Drug Product
Table 72. Regeneron Recent Developments/Updates
Table 73. Santen Corporation Information
Table 74. Santen Description and Business Overview
Table 75. Santen Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Santen Ophthalmol Drug Product
Table 77. Santen Recent Developments/Updates
Table 78. Bayer Corporation Information
Table 79. Bayer Description and Business Overview
Table 80. Bayer Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Bayer Ophthalmol Drug Product
Table 82. Bayer Recent Developments/Updates
Table 83. Pfizer Corporation Information
Table 84. Pfizer Description and Business Overview
Table 85. Pfizer Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Pfizer Ophthalmol Drug Product
Table 87. Pfizer Recent Developments/Updates
Table 88. Senju Corporation Information
Table 89. Senju Description and Business Overview
Table 90. Senju Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Senju Ophthalmol Drug Product
Table 92. Senju Recent Developments/Updates
Table 93. Akorn Corporation Information
Table 94. Akorn Description and Business Overview
Table 95. Akorn Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Akorn Ophthalmol Drug Product
Table 97. Akorn Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Ophthalmol Drug Distributors List
Table 101. Ophthalmol Drug Customers List
Table 102. Ophthalmol Drug Market Trends
Table 103. Ophthalmol Drug Growth Drivers
Table 104. Ophthalmol Drug Market Restraints
Table 105. Global Ophthalmol Drug Sales Forecast by Type (2022-2027) & (K MT)
Table 106. Global Ophthalmol Drug Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Ophthalmol Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Ophthalmol Drug Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Ophthalmol Drug Sales Forecast by Application (2022-2027) & (K MT)
Table 110. Global Ophthalmol Drug Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Ophthalmol Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Ophthalmol Drug Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Ophthalmol Drug Sales Forecast by Region (2022-2027) & (K MT)
Table 114. Global Ophthalmol Drug Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Ophthalmol Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Ophthalmol Drug Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Ophthalmol Drug
Figure 2. Global Ophthalmol Drug Market Share by Type in 2020 & 2027
Figure 3. Retinal disorders drugs Product Picture
Figure 4. Allergic, inflammatory and infective drugs Product Picture
Figure 5. Glaucoma drugs Product Picture
Figure 6. Dry eye drugs Product Picture
Figure 7. Global Ophthalmol Drug Market Share by Application in 2020 & 2027
Figure 8. Glaucoma
Figure 9. Dry eye syndrome
Figure 10. Retinal diseases
Figure 11. Other ophthalmic indications
Figure 12. Global Ophthalmol Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Ophthalmol Drug Market Size 2016-2027 (US$ Million)
Figure 14. Global Ophthalmol Drug Sales 2016-2027 (K MT)
Figure 15. Global Ophthalmol Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Ophthalmol Drug Sales Share by Manufacturers in 2020
Figure 17. Global Ophthalmol Drug Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Ophthalmol Drug Players: Market Share by Revenue in 2020
Figure 19. Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Ophthalmol Drug Sales Market Share by Region (2016-2021)
Figure 21. Global Ophthalmol Drug Sales Market Share by Region in 2020
Figure 22. Global Ophthalmol Drug Revenue Market Share by Region (2016-2021)
Figure 23. Global Ophthalmol Drug Revenue Market Share by Region in 2020
Figure 24. U.S. Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Colombia Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Ophthalmol Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Ophthalmol Drug by Type (2016-2021)
Figure 48. Sales Market Share of Ophthalmol Drug by Application (2016-2021)
Figure 49. Sales Market Share of Ophthalmol Drug by Application in 2020
Figure 50. Revenue Share of Ophthalmol Drug by Application (2016-2021)
Figure 51. Revenue Share of Ophthalmol Drug by Application in 2020
Figure 52. Manufacturing Cost Structure of Ophthalmol Drug
Figure 53. Manufacturing Process Analysis of Ophthalmol Drug
Figure 54. Ophthalmol Drug Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed